R1 RCM Inc (RCM)
12.36
+0.08
(+0.61%)
USD |
NASDAQ |
May 01, 16:00
12.36
0.00 (0.00%)
After-Hours: 20:00
R1 RCM Price to Book Value: 1.889 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 30, 2024 | 1.877 |
April 29, 2024 | 1.886 |
April 26, 2024 | 1.818 |
April 25, 2024 | 1.806 |
April 24, 2024 | 1.809 |
April 23, 2024 | 1.795 |
April 22, 2024 | 1.819 |
April 19, 2024 | 1.832 |
April 18, 2024 | 1.836 |
April 17, 2024 | 1.856 |
April 16, 2024 | 1.865 |
April 15, 2024 | 1.883 |
April 12, 2024 | 1.905 |
April 11, 2024 | 1.952 |
April 10, 2024 | 1.940 |
April 09, 2024 | 1.966 |
April 08, 2024 | 1.951 |
April 05, 2024 | 1.905 |
April 04, 2024 | 1.928 |
April 03, 2024 | 1.935 |
April 02, 2024 | 1.926 |
April 01, 2024 | 1.919 |
March 28, 2024 | 1.967 |
March 27, 2024 | 1.986 |
March 26, 2024 | 1.986 |
Date | Value |
---|---|
March 25, 2024 | 1.995 |
March 22, 2024 | 1.986 |
March 21, 2024 | 2.001 |
March 20, 2024 | 2.009 |
March 19, 2024 | 2.000 |
March 18, 2024 | 2.012 |
March 15, 2024 | 2.065 |
March 14, 2024 | 2.088 |
March 13, 2024 | 2.131 |
March 12, 2024 | 2.145 |
March 11, 2024 | 2.145 |
March 08, 2024 | 2.120 |
March 07, 2024 | 2.168 |
March 06, 2024 | 2.128 |
March 05, 2024 | 2.134 |
March 04, 2024 | 2.137 |
March 01, 2024 | 2.138 |
February 29, 2024 | 2.146 |
February 28, 2024 | 2.198 |
February 27, 2024 | 2.227 |
February 26, 2024 | 2.122 |
February 23, 2024 | 1.696 |
February 22, 2024 | 1.701 |
February 21, 2024 | 1.631 |
February 20, 2024 | 1.645 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.038
Minimum
Nov 09 2022
366.15
Maximum
Jun 28 2019
49.29
Average
20.09
Median
Dec 02 2021
Price to Book Value Benchmarks
Panamera Holdings Corp | -- |
Thermo Fisher Scientific Inc | 4.826 |
Sotera Health Co | 7.183 |
PetMed Express Inc | 0.8349 |
LENZ Therapeutics Inc | -- |
Price to Book Value Related Metrics
PE Ratio | 1308.33 |
PS Ratio | 2.441 |
Price to Free Cash Flow | 23.15 |
Price | 12.36 |
Earnings Yield | 0.08% |
Market Cap | 5.197B |
Operating PE Ratio | 20.80 |
Normalized PE Ratio | 68.42 |